Related references
Note: Only part of the references are listed.Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers
Susmita Mondal et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Metabolic Reprograming Via Silencing of Mitochondrial VDAC1 Expression Encourages Differentiation of Cancer Cells
Tasleem Arif et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
Danielle Golub et al.
FRONTIERS IN ONCOLOGY (2019)
Glutamine Addiction and Therapeutic Strategies in Lung Cancer
Karolien Vanhove et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance
Jayshree Hirpara et al.
REDOX BIOLOGY (2019)
A Novel Lactate Dehydrogenase Inhibitor, 1-(Phenylseleno)-4-(Trifluoromethyl) Benzene, Suppresses Tumor Growth through Apoptotic Cell Death
Eun-Yeong kim et al.
SCIENTIFIC REPORTS (2019)
Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
Thomas M. Ashton et al.
CLINICAL CANCER RESEARCH (2018)
Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events
Toshiaki Ohkuma et al.
DIABETOLOGIA (2018)
Non-small cell lung cancers with isocitrate dehydrogenase 1 or 2 (IDH1/2) mutations
Laura N. Toth et al.
HUMAN PATHOLOGY (2018)
The apple polyphenol phloretin inhibits breast cancer cell migration and proliferation via inhibition of signals by type 2 glucose transporter
Kuan-Hsun Wu et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2018)
Targeting the PI3K pathway in cancer: are we making headway?
Filip Janku et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
PTEN Deficiency and AMPK Activation Promote Nutrient Scavenging and Anabolism in Prostate Cancer Cells
Seong M. Kim et al.
CANCER DISCOVERY (2018)
Enhancing anticancer effects, decreasing risks and solving practical problems facing 3-bromopyruvate in clinical oncology: 10 years of research experience
Salah Mohamed El Sayed
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer
Xian Yu et al.
FRONTIERS IN GENETICS (2018)
Mitochondrial VDAC1 Silencing Leads to Metabolic Rewiring and the Reprogramming of Tumour Cells into Advanced Differentiated States
Tasleem Arif et al.
CANCERS (2018)
Nutrient scavenging in cancer
Brendan T. Finicle et al.
NATURE REVIEWS CANCER (2018)
Tumour microenvironment factors shaping the cancer metabolism landscape
Dimitrios Anastasiou
BRITISH JOURNAL OF CANCER (2017)
VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties
Tasleem Arif et al.
NEURO-ONCOLOGY (2017)
Physiological Effects of Chronic Hypoxia
John B. West
NEW ENGLAND JOURNAL OF MEDICINE (2017)
One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy
Oleg Shuvalov et al.
ONCOTARGET (2017)
Metabolic Hallmarks of Tumor and immune Cells in the Tumor Microenvironment
Kathrin Renner et al.
FRONTIERS IN IMMUNOLOGY (2017)
The Emerging Facets of Non-Cancerous Warburg Effect
Alyaa M. Abdel-Haleem et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Metabolic Plasiticy in Cancers-Distinct Role of Glycolytic Enzymes GPI, LDHs or Membrane Transporters MCTs
Masa Zdralevic et al.
FRONTIERS IN ONCOLOGY (2017)
Current Landscape of Targeted Therapy in Lung Cancer
Manasi K. Mayekar et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Lactate Metabolism in Human Lung Tumors
Brandon Faubert et al.
CELL (2017)
Synergistic antitumor effect of 3-bromopyruvate and 5-fluorouracil against human colorectal cancer through cell cycle arrest and induction of apoptosis
Dianlong Chong et al.
ANTI-CANCER DRUGS (2017)
One-carbon metabolism in cancer
Alice C. Newman et al.
BRITISH JOURNAL OF CANCER (2017)
Effect of 3-bromopyruvate acid on the redox equilibrium in non-invasive MCF-7 and invasive MDA-MB-231 breast cancer cells
Ewa Kwiatkowska et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2016)
Differential 3-bromopyruvate inhibition of cytosolic and mitochondrial human serine hydroxymethyltransferase isoforms, key enzymes in cancer metabolic reprogramming
Alessandro Paiardini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2016)
PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis
Debangshu Samanta et al.
CANCER RESEARCH (2016)
Metabolic Heterogeneity in Human Lung Tumors
Christopher T. Hensley et al.
CELL (2016)
Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer
Shawn M. Davidson et al.
CELL METABOLISM (2016)
Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination
Jason S. L. Yu et al.
DEVELOPMENT (2016)
Identifying Causes for Excess Mortality in Patients With Diabetes: Closer but Not There Yet
Oriana Hoi Yun Yu et al.
DIABETES CARE (2016)
The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside
J. Azevedo-Silva et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2016)
O-GIcNAcylation in Cancer Biology: Linking Metabolism and Signaling
Christina M. Ferrer et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
Detection of Lung Cancer through Metabolic Changes Measured in Blood Plasma
Evelyne Louis et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation
Min Pan et al.
NATURE CELL BIOLOGY (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
High Expression of PHGDH Predicts Poor Prognosis in Non-Small Cell Lung Cancer
Jinhong Zhu et al.
TRANSLATIONAL ONCOLOGY (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in Mice
Hans E. Purkey et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
Lactate Contribution to the Tumor Microenvironment: Mechanisms, effects on immune Cells and Therapeutic Relevance
Susana Romero-Garcia et al.
FRONTIERS IN IMMUNOLOGY (2016)
Fundamentals of cancer metabolism
Ralph J. DeBerardinis et al.
SCIENCE ADVANCES (2016)
13C MRS and LC-MS Flux Analysis of Tumor Intermediary Metabolism
Alexander A. Shestov et al.
FRONTIERS IN ONCOLOGY (2016)
A novel small-molecule inhibitor of 3-phosphoglycerate dehydrogenase
Edouard Mullarky et al.
MOLECULAR & CELLULAR ONCOLOGY (2016)
Serine and one-carbon metabolism in cancer
Ming Yang et al.
NATURE REVIEWS CANCER (2016)
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
Luana Schito et al.
TRENDS IN CANCER (2016)
A guide to immunometabolism for immunologists
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2016)
The mitochondrial voltage-dependent anion channel 1 in tumor cells
Varda Shoshan-Barmatz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA
Aik T. Ooi et al.
CLINICAL CANCER RESEARCH (2015)
Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?
Wen Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2015)
Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K
Rupert Courtnay et al.
MOLECULAR BIOLOGY REPORTS (2015)
Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth
Emma E. Vincent et al.
MOLECULAR CELL (2015)
p53 in survival, death and metabolic health: a lifeguard with a licence to kill
Flore Kruiswijk et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Pyruvate kinase: Function, regulation and role in cancer
William J. Israelsen et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)
Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy
Diana Cervantes-Madrid et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Genetic Disruption of Lactate/H+ Symporters (MCTs) and Their Subunit CD147/BASIGIN Sensitizes Glycolytic Tumor Cells to Phenformin
Ibtissam Marchiq et al.
CANCER RESEARCH (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
PCK2 activation mediates an adaptive response to glucose depletion in lung cancer
K. Leithner et al.
ONCOGENE (2015)
Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer
Madoka Kimura et al.
SUPPORTIVE CARE IN CANCER (2015)
Mitochondria as biosynthetic factories for cancer proliferation
Christopher S. Ahn et al.
CANCER & METABOLISM (2015)
2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
J. Vansteenkiste et al.
ANNALS OF ONCOLOGY (2014)
Altered Glutamine Metabolism and Therapeutic Opportunities for Lung Cancer
Amr Mohamed et al.
CLINICAL LUNG CANCER (2014)
Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors
E. M. Dunbar et al.
INVESTIGATIONAL NEW DRUGS (2014)
Quantitative Proteomic Approach to Understand Metabolic Adaptation in Non-Small Cell Lung Cancer
Alfonso Martin-Bernabe et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Serine and glycine metabolism in cancer
Ivano Amelio et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
The pentose phosphate pathway and cancer
Krushna C. Patra et al.
TRENDS IN BIOCHEMICAL SCIENCES (2014)
SHMT1 knockdown induces apoptosis in lung cancer cells by causing uracil misincorporation
A. Paone et al.
CELL DEATH & DISEASE (2014)
Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia
Jiangbin Ye et al.
CANCER DISCOVERY (2014)
The assessment and impact of sarcopenia in lung cancer: a systematic literature review
Jemima Collins et al.
BMJ OPEN (2014)
O-GlcNAcylation and metabolic reprograming in cancer
Pawel Jozwiak et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Metabolic changes in cancer: beyond the Warburg effect
Weihua Wu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2013)
LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin
David B. Shackelford et al.
CANCER CELL (2013)
Influence of Metabolism on Epigenetics and Disease
William G. Kaelin et al.
CELL (2013)
Targeting the RAS oncogene
Asami Takashima et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence
Joanna Kaplon et al.
NATURE (2013)
Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
Cosimo Commisso et al.
NATURE (2013)
Cracking the O-GlcNAc code in metabolism
Hai-Bin Ruan et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2013)
Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells
P. M. Tedeschi et al.
CELL DEATH & DISEASE (2013)
Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells
Julia Billiard et al.
CANCER & METABOLISM (2013)
Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis (vol 148, pg 259, 2012)
Wen Cai Zhang et al.
CELL (2012)
Anticancer Agents That Counteract Tumor Glycolysis
Carlotta Granchi et al.
CHEMMEDCHEM (2012)
c-Myc and Cancer Metabolism
Donald M. Miller et al.
CLINICAL CANCER RESEARCH (2012)
3-bromopyruvate: Targets and outcomes
Maria C. Shoshan
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2012)
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
Michael S. Goldberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Targeting glucose metabolism for cancer therapy
Robert B. Hamanaka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Phosphatidykinosital 3-Kinase and Mammalian Target of Rapamycin Pathway in Non–Small-Cell Lung Cancer
Erminia Massarelli et al.
Journal of Thoracic Oncology (2012)
A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo
Yi Liu et al.
MOLECULAR CANCER THERAPEUTICS (2012)
How cancer metabolism is tuned for proliferation and vulnerable to disruption
Almut Schulze et al.
NATURE (2012)
TKTL-1 expression in lung cancer
Peter Fritz et al.
PATHOLOGY RESEARCH AND PRACTICE (2012)
Phosphofructokinase 1 Glycosylation Regulates Cell Growth and Metabolism
Wen Yi et al.
SCIENCE (2012)
Glyceraldehyde-3-Phosphate Dehydrogenase: A Promising Target for Molecular Therapy in Hepatocellular Carcinoma
Shanmugasundaram Ganapathy-Kanniappan et al.
ONCOTARGET (2012)
Implications of quantum metabolism and natural selection for the origin of cancer cells and tumor progression
Paul Davies et al.
AIP ADVANCES (2012)
DNA Methylation and Nonsmall Cell Lung Cancer
Fang Lu et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2011)
O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy
Wenyi Mi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy
Gabriele D. Maurer et al.
BMC CANCER (2011)
Diabetogenic glucose and insulin concentrations modulate transcriptom and protein levels involved in tumour cell migration, adhesion and proliferation
K. Masur et al.
BRITISH JOURNAL OF CANCER (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells
Katarina Smolkova et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells
Sybille Mazurek
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
Peng Jiang et al.
NATURE CELL BIOLOGY (2011)
Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2
J. Chen et al.
ONCOGENE (2011)
Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses
Dimitrios Anastasiou et al.
SCIENCE (2011)
Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality
Denise A. Chan et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Glyoxalase in tumourigenesis and multidrug resistance
Paul J. Thornalley et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Novel N-phenyl dichloroacetamide derivatives as anticancer reagents: Design, synthesis and biological evaluation
Yongchong Yang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Reactive oxygen species in cancer
Geou-Yarh Liou et al.
FREE RADICAL RESEARCH (2010)
Regulation of Mammalian Muscle Type 6-Phosphofructo-1-kinase and Its Implication for the Control of the Metabolism
Mauro Sola-Penna et al.
IUBMB LIFE (2010)
Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
Ming Zhou et al.
MOLECULAR CANCER (2010)
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
G. L. Semenza
ONCOGENE (2010)
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Anne Le et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
EPIGENETICS AND GENETICS A census of amplified and overexpressed human cancer genes
Thomas Santarius et al.
NATURE REVIEWS CANCER (2010)
The bioenergetics of cancer: Is glycolysis the main ATP supplier in all tumor cells?
Rafael Moreno-Sanchez et al.
BIOFACTORS (2009)
The reverse Warburg effect Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Stephanos Pavlides et al.
CELL CYCLE (2009)
The Glycolytic Inhibitor 2-Deoxyglucose Activates Multiple Prosurvival Pathways through IGF1R
Diansheng Zhong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Insulin, the Insulin-Like Growth Factor Axis, and Mortality in Patients With Nonmetastatic Colorectal Cancer
Brian M. Wolpin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Association Between Hyperglycemia and Survival in Patients With Newly Diagnosed Glioblastoma
Rachel L. Derr et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Glyceraldehyde 3-Phosphate Dehydrogenase Depletion Induces Cell Cycle Arrest and Resistance to Antimetabolites in Human Carcinoma Cell Lines
Manali S. Phadke et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver
Weiqin Jiang et al.
CANCER RESEARCH (2008)
TKTL1 is overexpressed in a large portion of non-small cell lung cancer specimens
Holger Schultz et al.
DIAGNOSTIC PATHOLOGY (2008)
Is cancer a disease of abnormal cellular metabolism? New angles on an old idea
Ralph J. DeBerardinis
GENETICS IN MEDICINE (2008)
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Pierre Sonveaux et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death
Tabitha E. Wood et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth
Brian Clem et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Global Regulation of Nucleotide Biosynthetic Genes by c-Myc
Yen-Chun Liu et al.
PLOS ONE (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
MYC - TIMELINE Reflecting on 25 years with MYC
Natalie Meyer et al.
NATURE REVIEWS CANCER (2008)
GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation
Anna Colell et al.
CELL (2007)
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth
Sebastien Bonnet et al.
CANCER CELL (2007)
Energy metabolism in tumor cells
Rafael Moreno-Sanchez et al.
FEBS JOURNAL (2007)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
Valeria R. Fantin et al.
CANCER CELL (2006)
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib
DA Eberhard et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Transcriptional regulation and transformation by MYC proteins
S Adhikary et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
[18F]FDG uptake and PCNA, glut-1, and hexokinase-II expressions in ccancers and inflammatory lesions of the lung
M Mamede et al.
NEOPLASIA (2005)
Molecular pathology of non-small-cell lung cancer
RHJ Breuer et al.
RESPIRATION (2005)
KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib
W Pao et al.
PLOS MEDICINE (2005)
Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-D-glucose in tumor cells treated under hypoxic vs aerobic conditions
JC Maher et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes
B Altenberg et al.
GENOMICS (2004)
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo
G Maschek et al.
CANCER RESEARCH (2004)
Akt stimulates aerobic glycolysis in cancer cells
RL Elstrom et al.
CANCER RESEARCH (2004)
The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer
L Schrevens et al.
ONCOLOGIST (2004)
Lonidamine: Efficacy and safety in clinical trials for the treatment of solid tumors
S Di Cosimo et al.
DRUGS OF TODAY (2003)
Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: Final results of a phase III study with a factorial design
A Berruti et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism
MA Nikiforov et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Activation of the HIF pathway in cancer
PH Maxwell et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2001)
Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study
M De Lena et al.
EUROPEAN JOURNAL OF CANCER (2001)
Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancer
K Higashi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)
Share Paper
